Decreased occipital cortical glutamate levels in response to successful cognitive-behavioral therapy and pharmacotherapy for major depressive disorder

Psychotherapy and Psychosomatics

Volumn 83, Issue 5, 2014, Pages 298-307

  Abdallah, Chadi G ^a,c   Niciu, Mark J ^a   Fenton, Lisa R ^c   Fasula, Madonna K ^a   Jiang, Lihong ^b   Black, Anne ^a   Rothman, Douglas L ^b   Mason, Graeme F ^a,b   Sanacora, Gerard ^a  

^a Yale University School of Medicine   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Antidepressant; Cognitive behavioral therapy; Glutamate; Glutamine; Selective serotonin reuptake inhibitor; Aminobutyric acid

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMIC ACID; GLUTAMINE; SEROTONIN UPTAKE INHIBITOR; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER;

ADULT; AGED; ANTIDEPRESSANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; COGNITIVE THERAPY; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR DEPRESSION; MALE; OCCIPITAL CORTEX; PHARMACEUTICAL CARE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TREATMENT OUTCOME; TREATMENT RESPONSE; CHEMISTRY; DEPRESSIVE DISORDER, MAJOR; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OCCIPITAL LOBE; PSYCHOLOGICAL RATING SCALE; YOUNG ADULT; ATTITUDE ASSESSMENT; BECK DEPRESSION INVENTORY; BECK HOPELESSNESS SCALE; CLINICAL ASSESSMENT; CLINICAL FEATURE; DYSFUNCTIONAL ATTITUDE SURVEY; FOLLOW UP; HAMILTON ANXIETY SCALE; OPEN STUDY; OUTPATIENT; PSYCHOPHARMACOTHERAPY;

ADULT; ANTIDEPRESSIVE AGENTS; BIOMARKERS; COGNITIVE THERAPY; DEPRESSIVE DISORDER, MAJOR; GLUTAMIC ACID; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEUROTRANSMITTER AGENTS; OCCIPITAL LOBE; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84906033256     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000361078     Document Type: Article

References (58)

1. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE,Wang PS: The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).JAMA 2003; 289: 3095-3105.
2. Ustun TB, Ayuso-Mateos JL, Chatterji S,Mathers C, Murray CJ: Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004; 184: 386-392.
3. Ormel J, Petukhova M, Chatterji S, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, Bromet EJ, Burger H, Demyttenaere K, de Girolamo G, Haro JM, Hwang I, Karam E, Kawakami N,Lepine JP, Medina-Mora ME, Posada-Villa J,Sampson N, Scott K, Ustun TB, Von Korff M,Williams DR, Zhang M, Kessler RC: Disability and treatment of specific mental and physical disorders across the world. Br J Psychiatry 2008; 192: 368-375.
4. American Psychiatric Association: PracticeGuideline for the Treatment of Patients withMajor Depressive Disorder, ed 2. Washington,American Psychiatric Association, 2000.
5. Simons AD, Murphy GE, Levine JL, Wetzel RD: Cognitive therapy and pharmacotherapy for depression. Sustained improvement overone year. Arch Gen Psychiatry 1986; 43: 43-48.
6. Evans MD, Hollon SD, DeRubeis RJ, Piasecki JM, Grove WM, Garvey MJ, Tuason VB: Differential relapse following cognitive therapy and pharmacotherapy for depression. Arch Gen Psychiatry 1992; 49: 802-808.
7. Thase ME, Simons AD, McGeary J, Cahalane JF, Hughes C, Harden T, Friedman E: Relapse after cognitive behavior therapy of depression:potential implications for longer courses of treatment. Am J Psychiatry 1992; 149: 1046-1052.
8. Gloaguen V, Cottraux J, Cucherat M, Blackburn IM: A meta-analysis of the effects of cognitive therapy in depressed patients. J Affect Disord 1998; 49: 59-72.
9. Elkin I, Shea MT, Watkins JT, Imber SD,Sotsky SM, Collins JF, Glass DR, Pilkonis PA,Leber WR, Docherty JP, Fiester SJ, Parloff MB: National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness oftreatments. Arch Gen Psychiatry 1989; 46:971-982, discussion 983.
10. DeRubeis RJ, Gelfand LA, Tang TZ, Simons AD: Medications versus cognitive behavior therapy for severely depressed out patients:mega-analysis of four randomized comparisons.Am J Psychiatry 1999; 156: 1007-1013.
11. Stewart JW, Garfinkel R, Nunes EV, Donovan S, Klein DF: Atypical features and treatmentresponse in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Clin Psychopharmacol 1998; 18: 429-434.
12. Thase ME, Dube S, Bowler K, Howland RH,Myers JE, Friedman E, Jarrett DB: Hypothalamic-pituitary-adrenocortical activity andresponse to cognitive behavior therapy in unmedicated,hospitalized depressed patients.Am J Psychiatry 1996; 153: 886-891.
13. Robbins DR, Alessi NE, Colfer MV: Treatment of adolescents with major depression:implications of the DST and the melancholic clinical sub type. J Affect Disord 1989; 17: 99-104.
14. Thase ME, Friedman ES: Is psychotherapy an effective treatment for melancholia and other severe depressive states? J Affect Disord 1999;54: 1-19.
15. Brambilla P, Perez J, Barale F, Schettini G,Soares JC: GABAergic dysfunction in mood disorders. Mol Psychiatry 2003; 8: 721-737,715.
16. Petty F: GABA and mood disorders: a brief review and hypothesis. J Affect Disord 1995;34: 275-281.
17. Sanacora G, Mason GF, Rothman DL, Behar KL, Hyder F, Petroff OA, Berman RM, Charney DS, Krystal JH: Reduced corticalγ-aminobutyric acid levels in depressed patientsdetermined by proton magnetic resonancespectroscopy. Arch Gen Psychiatry 1999; 56: 1043-1047.
18. Sanacora G, Gueorguieva R, Epperson CN,Wu YT, Appel M, Rothman DL, Krystal JH,Mason GF: Subtype-specific alterations ofγ-aminobutyric acid and glutamate in patientswith major depression. Arch Gen Psychiatry 2004; 61: 705-713.
19. Hasler G, van der Veen JW, Tumonis T, Meyers N, Shen J, Drevets WC: Reduced prefrontalglutamate/glutamine and γ-aminobutyricacid levels in major depression determine dusing proton magnetic resonance spectroscopy.Arch Gen Psychiatry 2007; 64: 193-200.
20. Sanacora G, Mason GF, Rothman DL, Krystal JH: Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors.Am J Psychiatry 2002; 159: 663-665.
21. Sanacora G, Mason GF, Rothman DL, Hyder F, Ciarcia JJ, Ostroff RB, Berman RM, Krystal JH: Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry 2003; 160: 577-579.
22. Sanacora G, Fenton LR, Fasula MK, Rothman DL, Levin Y, Krystal JH, Mason GF: Corticalγ-aminobutyric acid concentrations in depressed patients receiving cognitive behavioral therapy. Biol Psychiatry 2006; 59: 284-286.
23. Deschwanden A, Karolewicz B, Feyissa AM,Treyer V, Ametamey SM, Johayem A, Burger C, Auberson YP, Sovago J, Stockmeier CA,Buck A, Hasler G: Reduced metabotropic glutamatereceptor 5 density in major depression determined by [ 11 C]ABP688 PET and postmortem study. Am J Psychiatry 2011; 168:727-734.
24. Feyissa AM, Chandran A, Stockmeier CA,Karolewicz B: Reduced levels of NR2A andNR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression.Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 70-75.
25. Bhagwagar Z, Wylezinska M, Jezzard P, Evans J, Boorman E, Matthews PM, Cowen PJ: Low GABA concentrations in occipital cortex andanterior cingulate cortex in medication-free,recovered depressed patients. Int J Neuropsychopharmacol 2008; 11: 255-260.
26. Michael N, Erfurth A, Ohrmann P, Arolt V,Heindel W, Pfleiderer B: Metabolic changes with in the left dorsolateral prefrontal cortexoccurring with electro convulsive therapy inpatients with treatment resistant unipolar depression.Psychol Med 2003; 33: 1277-1284.
27. Auer DP, Putz B, Kraft E, Lipinski B, Schill J,Holsboer F: Reduced glutamate in the anteriorcingulate cortex in depression: an in vivoproton magnetic resonance spectroscopy study. Biol Psychiatry 2000; 47: 305-313.
28. Zhang J, Narr KL, Woods RP, Phillips OR, Alger JR, Espinoza RT: Glutamate normalization with ECT treatment response in major depression. Mol Psychiatry 2013; 18: 268-270.
29. Michael N, Erfurth A, Ohrmann P, Arolt V,Heindel W, Pfleiderer B: Neurotrophic effects of electro convulsive therapy: a protonmagnetic resonance study of the left amygdalar region in patients with treatment-resistant depression. Neuropsychopharmacology2003; 28: 720-725.
30. Pfleiderer B, Michael N, Erfurth A, Ohrmann P, Hohmann U, Wolgast M, Fiebich M, Arolt V, Heindel W: Effective electro convulsivetherapy reverses glutamate/glutamine deficitin the left anterior cingulum of unipolar depressed patients. Psychiatry Res 2003; 122:185-192.
31. Beck AT, Rush AJ, Shaw BF, Emery G: Cognitive therapy of Depression, ed 2. New York,Guilford Press, 1987.
32. Young J, Beck AT: Cognitive Therapy Scale:Rating Manual. Philadelphia, University ofPennsylvania, 1980.
33. First M, Spitzer R, Gibbon M, Williams J:Structured Clinical Interview for DSM-IVAxis I Disorders: Patient Edition (SCIDI/P,version 2.0). New York, Biometric Research/New York State Psychiatric Institute, 1995.
34. Hamilton M: Development of a rating scalefor primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278-296.
35. Hamilton M: Diagnosis and rating of anxiety.Br J Psychiatry 1969; 3: 76-79.
36. Beck AT, Ward CH, Mendelson M, Mock J,Erbaugh J: An inventory for measuring depression.Arch Gen Psychiatry 1961; 4: 561-571.
37. Valentine GW, Mason GF, Gomez R, FasulaM, Watzl J, Pittman B, Krystal JH, Sanacora G: The antidepressant effect of ketamine isnot associated with changes in occipital aminoacid neurotransmitter content as measuredby [ 1 H]-MRS. Psychiatry Res 2011; 191:122-127.
38. Bhagwagar Z, Wylezinska M, Jezzard P, Evans J, Ashworth F, Sule A, Matthews PM, Cowen PJ:Reduction in occipital cortex γ-aminobutyricacid concentrations in medication-free recoveredunipolar depressed and bipolar subjects.Biol Psychiatry 2007; 61: 806-812.
39. Morgan PT, Pace-Schott EF, Mason GF,Forselius E, Fasula M, Valentine GW, Sanacora G: Cortical GABA levels in primary insomnia.Sleep 2012; 35: 807-814.
40. Grant BF, Stinson FS, Dawson DA, Chou SP,Dufour MC, Compton W, Pickering RP, KaplanK: Prevalence and co-occurrence of substanceuse disorders and independent moodand anxiety disorders: results from the National epidemiologic Survey on Alcohol andRelated Conditions. Arch Gen Psychiatry 2004; 61: 807-816.
41. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD,McGrath PJ, Rosenbaum JF, Sackeim HA,Kupfer DJ, Luther J, Fava M: Acute and longer-term outcomes in depressed out patients requiring one or several treatment steps: aSTAR * D report. Am J Psychiatry 2006; 163:1905-1917.
42. Rush AJ, Trivedi MH, Stewart JW, Nierenberg AA, Fava M, Kurian BT, Warden D,Morris DW, Luther JF, Husain MM, Cook IA,Shelton RC, Lesser IM, Kornstein SG, WisniewskiSR: Combining Medications to EnhanceDepression Outcomes (CO-MED):acute and long-term outcomes of a singleblindrandomized study. Am J Psychiatry2011; 168: 689-701.
43. Tomba E: Nowhere patients. Psychother Psychosom2012; 81: 69-72.
44. Fava M, Mischoulon D, Iosifescu D, Witte J,Pencina M, Flynn M, Harper L, Levy M, Rickels K, Pollack M: A double-blind, placebocontrolledstudy of aripiprazole adjunctive toantidepressant therapy among depressed out patientswith inadequate response to prior antidepressanttherapy (ADAPTA-A study).Psychother Psychosom 2012; 81: 87-97.
45. Goldapple K, Segal Z, Garson C, Lau M, Bieling P, Kennedy S, Mayberg H: Modulation ofcortical-limbic pathways in major depression:treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry 2004; 61: 34-41.
46. Bhagwagar Z, Wylezinska M, Taylor M, Jezzard P, Matthews PM, Cowen PJ: Increased brain GABA concentrations following acute administration of a selective serotonin reuptakeinhibitor. Am J Psychiatry 2004; 161:368-370.
47. Murck H, Schubert MI, Schmid D, Schussler P, Steiger A, Auer DP: The glutamatergic systemand its relation to the clinical effect of therapeutic-sleep deprivation in depression-an MR spectroscopy study. J Psychiatr Res 2009; 43: 175-180.
48. Price RB, Shungu DC, Mao X, Nestadt P, Kelly C, Collins KA, Murrough JW, Charney DS,Mathew SJ: Amino acid neurotransmitters assessedby proton magnetic resonance spectroscopy:relationship to treatment resistancein major depressive disorder. Biol Psychiatry 2009; 65: 792-800.
49. Fava GA: Modern psychiatric treatment: atribute to Thomas Detre, MD (1924-2011).Psychother Psychosom 2013; 82: 1-7.
50. Zantvoord JB, Diehle J, Lindauer RJ: Using neuro biological measures to predict and assess treatment outcome of psychotherapy in post traumatic stress disorder: systematic review.Psychother Psychosom 2013; 82: 142-151.
51. Keedwell P, Drapier D, Surguladze S, Giampietro V, Brammer M, Phillips M: Neural markers of symptomatic improvement during antidepressanttherapy in severe depression:subgenual cingulate and visual cortical responsesto sad, but not happy, facial stimuliare correlated with changes in symptomscore. J Psychopharmacol 2009; 23: 775-788.
52. Keedwell PA, Drapier D, Surguladze S, Giampietro V, Brammer M, Phillips M: Subgenualcingulate and visual cortex responses tosad faces predict clinical outcome during anti depressant treatment for depression. J Affect Disord 2010; 120: 120-125.
53. Furey ML, Drevets WC, Hoffman EM, Frankel E, Speer AM, Zarate CA Jr: Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder. JAMA Psychiatry 2013;70: 280-290.
54. Gabbay V, Mao X, Klein RG, Ely BA, Babb JS, Panzer AM, Alonso CM, Shungu DC:Anterior cingulate cortex γ-aminobutyric acid in depressed adolescents: relationshipto anhedonia. Arch Gen Psychiatry 2012; 69:139-149.
55. Sanacora G, Banasr M: From pathophysiologyto novel antidepressant drugs: glial contributionsto the pathology and treatment of mood disorders. Biol Psychiatry 2013; 73:1172-1179.
56. Popoli M, Yan Z, McEwen BS, Sanacora G:The stressed synapse: the impact of stress andglucocorticoids on glutamate transmission.Nat Rev Neurosci 2012; 13: 22-37.
57. Cao X, Li LP, Wang Q, Wu Q, Hu HH, Zhang M, Fang YY, Zhang J, Li SJ, Xiong WC, Yan HC, Gao YB, Liu JH, Li XW, Sun LR, Zeng YN, Zhu XH, Gao TM: Astrocyte-derivedATP modulates depressive-like behaviors.Nat Med 2013; 19: 773-777.
58. Manji H, Kato T, Di Prospero NA, Ness S,Beal MF, Krams M, Chen G: Impaired mitochondrialfunction in psychiatric disorders.Nat Rev Neurosci 2012; 13: 293-307.